CENTESSA PHARMACEUTICALS PLC
CNTA US1523091007
🆔
Registration No.
12973576
💰
Capitalization
Small-cap
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.
🏢
Founded
2020
🔗
Website
Annual Performance 1
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -48% | -73% | 154% | 109% | 0% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
📊
Transactions
85
🙍
Insiders
9
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Bush Tia L CTO |
24.00 USD |
35,000 Sold |
840,000 USD |
24/09/2025 | 24/09/2025 |
| Bush Tia L CTO |
24.00 USD |
35,000 Sold |
840,000 USD |
24/09/2025 | 24/09/2025 |
| Accardi Mario Alberto PR |
21.33 USD |
7,430 Sold |
158,506 USD |
16/09/2025 | 16/09/2025 |
| Accardi Mario Alberto PR |
22.02 USD |
742 Sold |
16,340 USD |
16/09/2025 | 16/09/2025 |
| Hussain Iqbal J SR OFF |
21.85 USD |
6,000 Sold |
131,101 USD |
15/09/2025 | 15/09/2025 |
| Bush Tia L CTO |
22.00 USD |
25,000 Sold |
550,000 USD |
09/09/2025 | 10/09/2025 |
| Hussain Iqbal J SR OFF |
22.00 USD |
20,000 Sold |
440,000 USD |
09/09/2025 | 10/09/2025 |
| Accardi Mario Alberto PR |
20.00 USD |
7,000 Sold |
140,000 USD |
09/09/2025 | 09/09/2025 |
| Bush Tia L CTO |
20.00 USD |
24,792 Sold |
495,840 USD |
09/09/2025 | 09/09/2025 |
| Hussain Iqbal J SR OFF |
20.01 USD |
20,000 Sold |
400,102 USD |
09/09/2025 | 09/09/2025 |